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Abstract
Background: Continuous-rate infusion (CRI) of drugs results in more stable plasma drug concentrations than
administration of intermittent boluses, thus providing greater stability of physiological parameters. The aim of this
study was to evaluate the physiologic and analgesic effects of the administration of morphine, butorphanol,
tramadol or methadone by CRI in horses with induced synovitis of the radiocarpal joint.
Results: Increased values of cardiorespiratory parameters and body temperature were observed in all groups after
initiation of opioid administration, and these increases were sustained throughout the CRI period. Morphine,
butorphanol and methadone each caused a reduction in gut sounds, and this effect was greatest in animals that
received morphine. Administration of morphine or methadone reduced the degree of lameness after the end of
intravenous infusion. Administration of tramadol did not alter the degree of lameness in the animals.
Conclusions: CRI of morphine or methadone, but not butorphanol or tramadol, provided analgesia in horses with
carpal synovitis. All of these opioids increased cardiovascular and respiratory parameters and reduced gut sounds
during CRI.
Keywords: Opioids, Analgesia, Inflammatory pain
Background
Despite the analgesia provided by opioids, in pain free
horses they may procude dose-dependent central nervous
system (CNS) excitation [1-3], increased spontaneous
locomotor activity [4] and reduced intestinal motility
[5,6]. Ataxia, shivering and restlessness have been re-
ported in horses that received a single IV injection of
0.1 mg/kg butorphanol [7,8]. The same side effects have
been reported for IV injection of 0.5 mg/kg methadone
[9]. Tramadol also elicited undesirable effects, espe-
cially muscle twitching and head nodding, after 1.5 or
3 mg/kg rapid IV administration [10]. Clinically rele-
vant doses of morphine (0.05 and 0.1 mg/kg) yielded
minimal and short-term cardiorespiratory, gastrointestinal
and behavioural effects, but analgesia was only achieved
for a short period of time in healthy conscious horses with
no signs of pain [11]. The dose, route, and duration of the
opioid treatment likely influenced whether adverse effects
developed and the severity of those effects [6,12].
The use of CRI minimises changes in plasma concen-
trations, which are frequent in intermittent bolus admin-
istrations. Side effects may be less likely to occur during
CRI because the total dose of the drug over time is lower
than the total administered boluses [7,13]. CRI of mor-
phine during inhalation anaesthesia did not promote any
haemodynamic or pulmonary changes [14], and it provided
a shorter, better-quality anaesthetic recovery compared to
the no-morphine group [14,15]. CRI of butorphanol caused
a lower incidence of behavioural and gastrointestinal al-
terations and lower plasma cortisol levels than the sa-
line group in horses after celiotomy [16]. Moreover, those* Correspondence: carregaro@usp.br1Department of Veterinary Medicine, University of São Paulo, Duque de
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horses displayed less weight loss while hospitalised and re-
covered quickly.
However, some studies report no advantages for CRI
of opioids in horses. Bettschart-Wolfensberger et al. [17]
observed no isoflurane-sparing effect with CRI of butor-
phanol, and animals that had received this opioid showed
longer times to extubation than receiving only medetomi-
dine [17]. Villalba et al. [18] reported that morphine did
not improve the isoflurane-sparing effect in horses under-
going CRI of ketamine plus lidocaine [18]. In another
study, CRI of morphine showed no advantages over CRI
of dexmedetomidine in isoflurane-anaesthetised horses
undergoing elective surgery [19]. Furthermore, horses
treated with morphine developed post-operative colic
and excitatory behaviour. To the authors’ knowledge,
no studies to date have determined whether a bolus
dose followed by CRI of tramadol or methadone pro-
vides analgesia in horses or whether it has an influence
on horse physiology.
The aim of this study was to evaluate the physiological
and analgesic effects of the administration of morphine,
butorphanol, tramadol or methadone by CRI in horses
subjected to synovitis induced by injection of Escherichia
coli lipopolysaccharide (LPS) into the radiocarpal joint.
Methods
This study was approved by the University of São Paulo
Animal Care Committee, under protocol number 2012.
1.106.74.4. Fourteen adult horses from the University of
São Paulo farm were used in the experiment, 9 females
and 5 males weighing between 350 and 500 kg, and they
were considered clinically healthy as assessed by clinical
examination and laboratory tests (complete blood count,
and biochemical profile). The study consisted of four ex-
perimental groups, with each animal participating in two
out of the four conditions. The washout period between
the treatments was at least one month.
For induction of synovitis, 0.5 ng of LPS of the Escher-
ichia coli strain 055:B5 (E. coli 055:B5; Sigma Chemical
Co., St Louis, MO, USA) was aseptically administered
into the right or left radiocarpal joint according to the
experimental design. The LPS was diluted in phosphate-
buffered saline (pH 7.4) to a final volume of 1 mL for
each administration. After clinical examination of the
physiological parameters (baseline), the animals were
sedated with 1 mg/kg xylazine IV (Sedazine - Schering-
Plough, Rio de Janeiro, RJ, Brazil). Once sedated, the
horses were given an intra-articular administration of
LPS [20].
Only two of the horses were submitted to a trial study
without any opioid treatment. The trial study revealed
that within three hours post-induction of synovitis, there
was already an evident degree of lameness (3 or 4).
Accordingly, three hours after LPS injection, jugular
venipuncture was performed with a 14G catheter and
used for the administration of one of four CRI treatments:
morphine (Mo, bolus of 0.15 mg/kg followed by CRI of
0.1 mg/kg/h morphine; Dimorf 10 mg/mL, Cristalia
Prod Quim Farm Ltda, Itapira, SP, Brazil), butorphanol
(B, bolus of 25 μg/kg followed by CRI of 25 μg/kg/h
butorphanol; Torbugesic, Fort Dodge Saude Animal Ltda,
Campinas, SP, Brazil), tramadol (T, bolus of 1.5 mg/kg
followed by CRI of 1 mg/kg/h tramadol; Tramadon,
Cristalia Ltda, Itapira, SP, Brazil) or methadone (Me, bolus
of 0.25 mg/kg followed by CRI of 0.25 mg/kg/h metha-
done; Mytedon 10 mg/mL, Cristalia Ltda, Itapira, SP,
Brazil). All treatments were assigned in a randomised
manner. The bolus and infusions were administered using
a syringe infusion pump (DigiPump SR8x, Digicare Ani-
mal Health, Boynton Beach, FL, USA) and maintained for
three hours, where the volumes were standardised with a
bolus of 17 mL/10 min and CRI of 50 mL/h such that the
observers were blinded to the treatment.
Physiological parameters and analgesia were evaluated
before sedation (baseline) and 1.5, 3, 4, 5, 6, 7, 8, 9, 10,
12, 14, 16 and 24 hours after induction of synovitis.
Heart rate (HR) was determined with a stethoscope bet-
ween the 3rd and 6th intercostal space and was measured
in beats per minute (bpm). Systolic arterial pressure (SAP)
in mmHg was measured non-invasively using an ultra-
sonic Doppler (Doppler, model 841 A, Parks Medical Elec-
tronics) with the transducer positioned over the coccygeal
artery at the base of the tail. The measurements were
taken with the cuff positioned cranially to the transducer
such that the cuff ’s width was half the diameter of the tail
[21]. The respiratory rate (RR) was measured by manually
counting chest movements per minute (mpm), and the
core body temperature (T°C) was measured with a flex-
ible digital thermometer (Pro-Check, ONBO Electron-
ics, USA) inserted approximately 3 cm into the rectum.
Gut sounds were evaluated by abdominal auscultation,
dividing the right lateral flank into two portions and de-
termining the opening of the ileocecal valve (dorsal por-
tion) and the right ventral colon (ventral portion). The
same procedure was performed on the left side. Each
quadrant was auscultated for one minute, with an in-
terval of a few seconds between quadrants. Scores of 0
to 4 were noted and later summed, resulting in values
between 0 and 16 [1].
To assess lameness, the horses were recorded while
being led at a walk and at a trot in a straight line (50
metres) on a hard surface. The images were analysed in
a random order, after the end of all treatments, by an
experienced observer (Dr. Dória) who was unaware of
the treatments used and the time of each measurement.
The lameness was scored as follows: 0, absence of visible
lameness; 1, discrete asymmetry, occasionally inconsistent;
2, visible lameness, rarely inconsistent; 3, visible lameness
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at all times; and 4, no weight bearing [22]. The highest
scores for walking or trotting were considered for stat-
istical purposes. At each evaluation point, physiological
parameters were measured before each lameness assess-
ment. CRI of the opioid was interrupted for only two mi-
nutes at 3, 4 and 5 hours so that the animal’s walking and
trotting could be filmed.
Rescue analgesia was administered to animals that
showed after each evaluation, a lameness score of 3 or
4 and that did not show any improvement of gait, or
that showed any signs of moderate to severe pain at
6 hours (end of CRI). This was evaluated by one experi-
enced observer (Dr. Carregaro) who was unaware of all
treatments. For rescue analgesia, 0.1 mg/kg morphine
and 1 mg/kg flunixin meglumine were administered IV.
The animals were then continuously monitored to check
the improvement of their clinical status. All animals were
given 1 mg/kg flunixin meglumine IV once a day for three
days after the evaluation period.
Statistical analysis was conducted using GraphPad Prism
(GraphPad Software, San Diego, CA, USA). The parame-
tric variables HR, SAP, RR and T°C were evaluated by ana-
lysis of variance (ANOVA) with Dunnett’s post-test for
comparisons of means within each group in relation to
baseline. Comparisons between groups at each time were
performed with one-way ANOVA followed by Tukey’s test.
The Friedman test was utilised for the non-parametric var-
iables gut sounds and lameness. The parametric results
were expressed as mean ± standard deviation, and the non-
parametric results were expressed as the median and inter-
quartile range. Differences were considered significant
when P < 0.05.
Results
At 3 hours, all animals showed signs of pain, such as
lowered head, reluctance to move, and a peculiar facial
expression [23] with stiffly backward ears, orbital tight-
ening, strained nostrils and flattening of the profile. Dur-
ing CRI, signs of restlessness were observed in two
animals in the B group, two in the Mo group and one in
the Me group. These animals showed continuous head
nodding, digging, and shifting of limbs. In contrast, the
other animals in the same groups remained calm during
CRI. No animal in the T group showed excitation, but all
animals were unable to stand on the affected leg and
shifted weight to their hind legs. Skin twitching was also
observed in four animals in the T group and three in the
Me group, particularly in the upper regions of the fore-
limbs and the dorsolateral area of the thorax and abdo-
men, especially during the first 30 minutes after bolus
injection.
All groups showed an increase in cardiorespiratory pa-
rameters after the beginning of the treatments, with a
marked increase in HR in animals of the B and Mo
groups and in SAP in all groups. After the end of the
treatments (6 hours), the parameters gradually returned
to the baseline values. Temperature increased in the Mo,
B and T groups; it increased between 4 hours and
7 hours in the T group (the last time point evaluated in
this group) and to 14 hours in the Mo, Me and B groups
(Figure 1). There was a marked decline in gut sounds in
the Mo group at 4 hours, and this effect persisted up to
8 hours. Additionally, reduced gut sounds were observed
in the Me and B groups during the infusion period. This
effect was not observed in the T group (Figure 1). Not-
ably, all animals in the T group defaecated at least once
during the three hours in the stock. Defaecation was also
observed for two animals in the B group and for none in
the Mo and Me groups.
Lameness was moderate at 1.5 hours and severe at
3 hours after LPS injection [22]. After 3 hours, and as in
the pilot study, practically all animals showed the max-
imal degree of lameness except for two animals in the T
group and one animal in the Me group, which showed a
score of 3. During CRI, gradual improvement was noted
in the Mo and Me groups. Moreover, both groups de-
monstrated better lameness scores, starting at 6 hours,
whereas the animals in the B group only showed im-
provement starting at 8 hours. No improvement was ob-
served in the animals in the T group (Table 1).
All animals in the T group required rescue analgesia at
the end of the treatment, among which four were res-
cued at 6 hours and two at 7 hours. Two animals in the
B group were rescued at 6 hours, and only one animal in
the Mo group was rescued at the same time. None of
the animals in the Me group required rescue analgesia.
All rescued animals showed improvement that was evi-
dent approximately 15 minutes after treatment. After an
hour, lameness was minimal or absent, and the physio-
logic parameters were close to normal for the species.
The data obtained after rescue are not shown and were
not considered for statistical evaluation. All animals, res-
cued or not, showed normal mobility at 24 hours post
LPS injection.
Discussion
Our results showed a marked reduction in the lameness
of animals treated with morphine or methadone, demon-
strating that CRI treatments were reasonably effective
against experimentally induced inflammatory joint pain.
Moreover, there was no need for rescue analgesia in an-
imals treated with methadone. Methadone has a mu-
receptor affinity similar to the affinity of morphine [24],
but one should consider that the dose of methadone
was twice as high as the morphine dose and must have
contributed to the higher analgesic effect. Information
about the analgesic effects of methadone in horses is
limited, but recently, it was demonstrated that a single
Carregaro et al. BMC Veterinary Research  (2014) 10:966 Page 3 of 8
IV dose of 0.2 mg/kg did not produce a consistent anti-
nociceptive effect to thermal and electrical stimuli. The
administration of 0.5 mg/kg induced short-acting anti-
nociception but may have been limited due to adverse
behavioural effects and ataxia in horses [9].
To the authors’ knowledge, there are no published
studies in which only morphine administered as a CRI
was used as a unique treatment in clinical studies of
horses. The available studies report the antinociceptive
effects of morphine in inhalation anaesthesia [14] or com-
bined with other analgesics [18,25,26]. The morphine dose
chosen for treatment was the same as that used in the
studies of Clark et al., who showed that horses receiv-
ing morphine during the anaesthetic period tended to
receive fewer and lower doses of additional anaesthetic
drugs in the intra- and postoperative periods [14] and
to recover better from the anaesthesia [15] than control
animals.
Figure 1 Effects of 0.25 mg/kg + 0.25 mg/kg/h methadone (Me), 0.15 mg/kg + 0.1 mg/kg/h morphine (Mo), 25 μg/kg + 25 μg/kg/h
butorphanol (B), and 1.5 mg/kg + 1 mg/kg/h tramadol (T) on heart rate (HR – 1A; bpm – beats/minute), systolic arterial pressure
(SAP – 1B; mmHg), respiratory rate (RR – 1C; bpm – breaths/minute), core body temperature (T°C – 1D; °C), and gut sounds score (1E)
of horses (n = 6) submitted to the experimental synovitis model. Values are reported as the mean ± SEM. Treatments were at 3 to 6 hours
(in grey). The pilot study was conducted with 2 horses that received no opioid treatment (--- Trial). *Within each group, values differ significantly
(P < 0.05) from the baseline value (0 minute). Values at the same time point in squares/rectangles indicate no significant difference (P < 0.05).
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Table 1 Degree of lameness of horses (n = 6) submitted to the experimental synovitis model and treated with 0.25 mg/kg + 0.25 mg/kg/h methadone (Me),
0.15 mg/kg + 0.1 mg/kg/h morphine (Mo), 25 μg/kg + 25 μg/kg/h butorphanol (B), and 1.5 mg/kg + 1 mg/kg/h tramadol (T)
Time (hours)
Continuous rate infusion
0 1.5 3 4 5 6 7 8 9 10 12 14 24
Lameness score Me 0 (0–0) 1.5 (0.5-2)* 4 (3.5-4) 3.5 (3–4) 2 (2–2.5)a 1 (1–1.5)*a 1.5 (0.5-2)*a 1.5 (1–2)* 1 (1–1.5)* 1 (1–1.5)* 1.5 (1–2)* 1 (1–1.5)* 0 (0–0)*
Mo 0 (0–0) 3 (2–3) 4 (4–4) 4 (3.5-4) 3 (3–4)ab 2 (2–3)*a 2.5 (2–3)*a 2 (2–3)* 2 (2–3)* 2 (2–2.7)* 2 (1.2-2.7)* 2 (1.2-2.7)* 0 (0–1)*
B 0 (0–0) 2 (2–3)* 4 (4–4) 4 (4–4) 4 (4–4)ab 4 (4–4)b 3 (2.5-3)a 2 (1.5-3)* 2 (1–3)* 2 (1–3)* 1.5 (0–2.2)* 1.5 (0–2)* 0 (0–0)*
T 0 (0–0) 3 (2.7-3) 4 (3–4) 4 (3.7-4) 4 (3–4)b 4 (3–4)b 3.5 (3–4)b -- -- -- -- -- 0 (0–0)*
Trial 0 (0–0) 3 (3–3) 4 (4–4) 4 (4–4) 4 (4–4) 4 (4–4) 4 (4–4) 4 (4–4) 3.5 (3–4) 4 (4–4) 3 (3–3) 3 (3–3) 1.5 (1–2)
The pilot study was conducted with 2 horses that received no opioid treatment (Trial). Values reflect the median and interquartile range.
Continuous rate infusion was performed between 3 and 6 hours (grey).
*Difference relative to 3-hour baseline.
Within a time point, values with different letters differ significantly.
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The bolus dose and CRI of butorphanol were in ac-
cordance with those used by other authors [16,27,28].
However, it should be noted that there was no standard-
isation of the dose or of the time of infusion. Even less
information is available for tramadol and methadone in
horses, which still have not been tested using CRI in this
species. The choice of the tramadol doses was based on
Grond & Sablotzki (2004) [29], who noted that the po-
tency was approximately 10% of that of morphine. As no
studies using methadone administered by CRI in horses
exist, the bolus and CRI rate were established based on
Linardi et al. [30], who showed that a single 0.15 mg/kg
dose of methadone was insufficient to promote anal-
gesia, and based on Oliveira et al. [9], who studied two
doses of methadone (0.2 and 0.5 mg/kg) and observed
that the higher dose promoted intense ataxia.
One study showed that morphine failed to promote
analgesia when administered in a single dose to treat
thermal and electrical noxious stimuli [11]. A single dose
(0.25 mg/kg) of morphine did not cause an appreciable
change in the minimum alveolar concentration of iso-
flurane, and it was not indicated for routine clinical use
as an adjuvant to isoflurane anaesthesia in horses [31].
However, both studies were performed with an electrical
and/or thermal stimulus, which may not represent inflam-
matory pain. As noted for CRI, Clark et al. [14] suggested
that a dose of 0.15 mg/kg followed by 0.1 mg/kg/h of mor-
phine appeared to produce analgesia in animals undergo-
ing surgery. However, this study did not state how long
the infusion was administered; this parameter could have
influenced the results, as the results obtained here only
demonstrated efficacy after 3 hours of infusion.
CRI of butorphanol decreased lameness only at 8
hours. Nonetheless, the results should be interpreted
with caution, as two animals required rescue analgesia
(Dr. Carregaro’s evaluation), and the lameness scores
were higher than those after morphine and methadone
treatment, demonstrating a clinical difference. Further-
more, if the lameness scores indicated by Dr. Dória were
considered for establishing rescue analgesia, not two but
rather five horses should have received it, demonstrating
the ineffectiveness of CRI with butorphanol. Although the
observers were experienced in the evaluation of lameness
in horses, it should be noted that variations can occur,
mainly because of the use of subjective scales [32], thereby
resulting in differences among the authors’ scores.
We were not able to demonstrate analgesia with tram-
adol. The analgesic action of tramadol in horses has
been studied in the past few years, but only one study
reports transient analgesia in horses with pain caused
by chronic laminitis. In that study, tramadol alone (orally
at 5 mg/kg every 12 h) provided limited pain relief,
and it was only effective when combined with CRI of
ketamine [33].
The lack of analgesia may have resulted from the bio-
transformation of tramadol in the horses. In horses, tram-
adol likely undergoes hepatic biotransformation [34] and
also produces at least five metabolites [35,36]. The main
active metabolite of tramadol, O-desmethyltramadol,
acts on opioid receptors. N-desmethyltramadol is the
inactive metabolite [34]. Although it has been suggested
that N-desmethyltramadol is the major metabolite pro-
duced [34,35], recent studies have demonstrated that
horses are very efficient in metabolising tramadol to
O-desmethyltramadol (phase I reaction). However, the
latter metabolite is rapidly and extensively conjugated
with glucuronic acid (phase II reaction) such that the
fraction of nonconjugated O-desmethyltramadol in plas-
ma is truly low [10,37,38]. In light of this biotransfor-
mation, we proposed a treatment of CRI with tramadol in
horses. Thus, it was speculated that the accumulation of
O-desmethyltramadol, combined with other pathways of
action for tramadol, could provide analgesia, but the re-
sults showed no effect for tramadol. Another possibility is
that the lack of analgesia may have resulted from the dose
chosen, which may have been sub-therapeutic.
Prior to CRI opioid administration, there was a slight
increase in cardiorespiratory parameters in all groups,
indicating the physiological effects of the pain model
that was used. Regarding morphine and butorphanol,
some papers report an absence of cardiovascular alte-
rations upon CRI administration to horses. The use of
butorphanol was not associated with cardiovascular chan-
ges, even during a 24-hour infusion [7]. Another study
also showed that morphine did not induce cardiovascular
changes in horses, but the animals were under inhalation
anaesthesia [14]. Additionally, restlessness may have in-
duced the increase in these parameters in the Mo, B and
Me groups. Despite the lack of differences among the
groups during CRI, higher SAP values were observed in
all animals; they markedly decreased after the infusions,
indicating that the opioids increased the SAP values
[24,27,39].
We also suggest that the physiologic changes in the T
group may have resulted from the synovitis model,
mainly considering the ineffectiveness of tramadol. This
idea is reinforced by the few studies that report no sub-
stantial changes in cardiovascular parameters, even with
such higher doses as 2 and 5 mg/kg of tramadol [40-42].
In relation to the influence of pain and opioids on car-
diovascular parameters, the inclusion of a real control
group, i.e., a synovitis-only group, could have addressed
this concern. However, for ethical reasons, such a group
was not used.
Despite the reduced doses of opioids used during the CRI
in this study, reduced gut sounds were still observed from
the start of the infusion of butorphanol, methadone and
especially of morphine. Thus, not only the pure agonists
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but also butorphanol caused a reduction in gut sounds. In
other studies, gut sounds did not vary significantly either
during or after CRI of butorphanol, but the number of
faecal piles passed during the 24-hour treatment period
was reduced [7,16]. This finding should be carefully con-
sidered because of the strong call for the use of butorpha-
nol in horses, as this drug theoretically has little influence
on gut sounds. No changes in gut sounds were observed
in the T group, corroborating other authors [33,40]. In
contrast, another study reported a case of mild colic in
one horse after six consecutive doses of 10 mg/kg trama-
dol. Thus, gastrointestinal depression with tramadol may
not be common, but it is possible.
Hyperthermia was observed in the Mo, B and T groups
and could have occurred as a result of the direct LPS
action on the thermoregulatory centre and through the
synthesis and secretion of endogenous pyrogens from
neutrophils and mononuclear phagocytes, which are re-
leased as a result of joint inflammation [43]. However,
given that the Me group animals did not show hyper-
thermia, methadone may also have anti-inflammatory
properties [44].
Some limitations should be considered in the present
study. The inclusion of a control group could show the
influence of pain and opioid on cardiovascular parameters.
In addition, if a dose–response study had been performed,
we could have drawn a proper comparison between the
analgesic effects of morphine and methadone and even
examined the reason why tramadol and butorphanol were
not effective as administered in this study. Furthermore, it
is important to point out that the dose of methadone was
twice as high as the morphine dose, which must have con-
tributed to the superior analgesic effect of methadone over
morphine.
Conclusions
Infusions of morphine and methadone reduced the pain
of horses with carpal synovitis. However, it is suggested
that CRI of these opioids in horses can increase cardio-
vascular and respiratory variables in addition to causing
reduced gut sounds.
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